TerminatedNot Applicable

Prospective Treatment Study of Catatonia Patients

Stopped: Unable to enroll

United States2 participantsStarted 2017-01

Plain-language summary

The purpose of this treatment study is to compare the effectiveness of different electrode placements used in Electroconvulsive Therapy (ECT) in the treatment of catatonia. In this study Electroconvulsive Therapy will be compared to medications used in the treatment of catatonia. Medications will be administered by the primary team as part of standard of care. Medications are not primarily being used as a part of this research study. This treatments study, will be able to compare response rate of catatonia to right unilateral electroconvulsive treatment (RUL ECT) and Bilateral electroconvulsive treatment (BL ECT). Also having a control group of catatonia patients, which will not be treated with ECT will provide additional information on early ECT treatment of Catatonia.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients admitted to WFBMC Inpatient Psychiatry unit with catatonia who are clinically eligible for ECT. * Clinical catatonia as evidenced by a Bush-Francis Catatonia Rating Scale (BFCRS) score of 4 or more Exclusion Criteria: * Pregnant women Patients with any of the following medical conditions which are contraindications for ECT: * Pheochromocytoma * History of stroke within the past 3 months * Cardiac conduction defects * Cerebral or aortic aneurysms

What they're measuring

Catatonia on the Bush- Francis Scale (BFCRS) - Pre

Timeframe: Prior first ECT treatment

Catatonia on the Bush- Francis Scale (BFCRS) - Pre

Timeframe: 1 day post first ECT treatment

Trial details

NCT IDNCT02734498

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-03-19

Results submitted2019-06-13